- Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist tirzepatide for type 2 diabetes: A systematic review and meta-analysis(2024)
Auteurs: Robin Lemmens
- Sex Differences in Outcomes of Late-Window Endovascular Stroke Therapy(2024)
Auteurs: Jelle Demeestere, Robin Lemmens, Lieselotte Vandewalle, Anke Wouters
Pagina's: 278 - 287
- Tau Imaging in Late Traumatic Brain Injury: A [18F]MK-6240 Positron Emission Tomography Study(2024)
Auteurs: Greet Vanderlinden, Michel Koole, Robin Lemmens, Bart Depreitere, Mathieu Vandenbulcke, Koen Van Laere
Pagina's: 420 - 429
- Effect of the Factor XIa Inhibitor Asundexian According to Baseline Infarct Pattern and on MRI Covert Infarct Outcomes(2024)
Auteurs: Robin Lemmens
Pagina's: 392 - 402
- Safety and efficacy of platelet glycoprotein VI inhibition in acute ischaemic stroke (ACTIMIS): a randomised, doubleblind, placebo-controlled, phase 1b/2a trial(2024)
Auteurs: Robin Lemmens
Pagina's: 157 - 167
- Error Enhancement for Upper Limb Rehabilitation in the Chronic Phase after Stroke: A 5-Day Pre-Post Intervention Study(2024)
Auteurs: Marjan Coremans, Robin Lemmens, Geert Verheyden
- Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational study(2024)
Auteurs: Robin Lemmens
Pagina's: 20 - 29
- Immediate Carotid Artery Stenting or Deferred Treatment in Patients With Tandem Carotid Lesions Treated Endovascularly for Acute Ischaemic Stroke(2024)
Auteurs: Robin Lemmens
Pagina's: 31 - 35
- Tenecteplase for the treatment of acute ischemic stroke in the extended time window: a systematic review and meta-analysis(2024)
Auteurs: Robin Lemmens
- Penumbral Rescue by normobaric O?=?O administration in patients with ischemic stroke and target mismatch proFile (PROOF): Study protocol of a phase IIb trial(2024)
Auteurs: Robin Lemmens
Pagina's: 120 - 126